RRM2 targeting siRNA therapeutics (Tech Manage)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameRRM2 targeting siRNA therapeutics (Tech Manage)
Drug Alias Nameribonucleotide reductase M2 subunit targeting siRNA therapeutics (Tech Manage)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRibonucleoside-diphosphate reductase subunit M2 modulators
TargetsRibonucleoside-diphosphate reductase subunit M2
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTech Manage Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTech Manage Corp
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A